Chronic risk reduction

Blockers (without ISA) are first-line therapy in chronic stable angina and have the ability to reduce BP, improve myocardial consumption, and decrease demand. Long-acting CCBs are either alternatives (the nondihy-dropyridines verapamil and diltiazem) or add-on therapy (dihydropy-ridines) to /1-blockers in chronic stable angina. Once ischemic symptoms are controlled with /1-blocker and/or CCB therapy, other antihypertensive drugs (e.g., ACE inhibitor, ARB) can be added to provide additional CV risk reduction. Thiazide diuretics may be added thereafter to provide additional BP lowering and further reduce CV risk. 

If the exposure had been much smaller, the risk calculation would have been less direct and less certain. For purposes of risk reduction in public health, we may choose to err on the pessimistic side in risk estimations. For purposes of attribution, however, we want to make best estimates. Most of the numbers in Ikble 8.4 are overestimates of the risks. For radiation-induced leukemia, as described in Section 6.1.2, the best dose-incidence model might be lineai>quadratic and not linear. Thus, someone exposed to 50 mSv (5 rem) might be considered, on a linear extrapolation basis, to have a radiation related lifetime risk of cancer mortality of 10 (2 x 10 Sv 2 x 10 rem ), or a lifetime risk of mortality from leukemia of approximately 1.5 x 10 (0.3 x 10" Sv 0.3 X 10 rem ). The natural lifetime risk of mortality from leukemia other than chronic lymphocytic leukemia is approximately 56 x 10 . Therefore, the percent attribution to radiation according to the linear model would be ... 

The effects of coenzyme Q10 on coronary artery disease and chronic stable angina are modest but appear promising. A theoretical basis for such benefit could be metabolic protection of the ischemic myocardium. Double-blind, placebo-controlled trials have demonstrated that coenzyme Q10 supplementation improved a number of clinical measures in patients with a history of acute myocardial infarction (AMI). Improvements have been observed in lipoprotein a, high-density lipoprotein cholesterol, exercise tolerance, and time to development of ischemic changes on the electrocardiogram during stress tests. In addition, very small reductions in cardiac deaths and rate of reinfarction in patients with previous AMI have been reported (absolute risk reduction 1.5%). 

Fundamental questions exist on (1) the criteria to be used to identify those substances that have the capacity to increase the risk of human cancer, (2) their mechanisms of action, and (3) the magnitude of the risk posed by episodic or chronic regular exposure. The answers to these questions lead to major public policy determinations based on the validity and significance of the real or postulated effects, the feasibility of the possible risk reduction measures, and the economic and social costs of those measures. In a society with finite resources at its... 

A irin has been shown to reduce die risk of a first myocardial inferction in patients with chronic stable angina in two studies, hi the first (a subgroup of the Physicians Health Study referenced above) there was a risk reduction at least as significant as that for the healfoy men emolled in the same trial (42). In the second randomized trial of 2,035 patients, there was a 34% reduction in the incidence of first myocardial induction and sudden cardiac death associated with aspirin (43). 

A goal BP of less than 140/90 mm Hg is appropriate for most patients. Achieving lower BP values has not been proven to provide additional risk reduction, except in patients with diabetes or chronic kidney disease. These patients have a goal BP of less than 1 30/80 mm Hg. 

Long-acting CCBs traditionally have been viewed as alternatives to /3-blockers in chronic stable angina. The INVEST study has compared /3-blocker with diuretic therapy with nondihydropyridine CCB with ACE inhibitor therapy in this population and has shown no difference in cardiovascular risk reduction. Nonetheless, the preponderance of data are with /3-blockers, and they remain therapy of choice. ... 

Not surprisingly then, the effect of smoking cessation on the prognosis of patients with chronic ischemic heart disease is substantial. In one meta-analysis by Critchley and Capewell (113), smoking cessation in patients with established CHD resulted in a crude 36% reduction in crude relative risk of all-cause mortality. The crude risk reduction for nonfatal reinfarction was 32%. 

Program Directives Expedite response actions for near-term impacts (e.g., current or imminent exposure above safe chronic level), and target available resources toward principal risk drivers so as to maximize risk reduction. 

Mayne TJ, Whalen E, Vu A. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions. Journal of Clinical Epidemiology 2006 59 217-223. 

A large body of observational studies suggests that high blood concentrations of carotenoids obtained from food are associated with chronic disease risk reduction. However, there is little other evidence of their specific role in the body. Lutein and zeaxanthin are the only carotenoids found in a specific tissue (the macular region of the retina) that seem to have a specific function. Providing lutein in the diet increases macular... 

Kushi LH, Meyer KA, and Jacobs Jr DR (1999) Cereals legumes and chronic disease risk reduction Evidence from epidemiologic studies. American Journal of Clinical Nutrition 70 451S-458S. 

There are hundreds of topical steroid preparations that are available for the treatment of skin diseases. In addition to their aforementioned antiinflammatory effects, topical steroids also exert their effects by vasoconstriction of the capillaries in the superficial dermis and by reduction of cellular mitosis and cell proliferation especially in the basal cell layer of the skin. In addition to the aforementioned systemic side effects, topical steroids can have adverse local effects. Chronic treatment with topical corticosteroids may increase the risk of bacterial and fungal infections. A combination steroid and antibacterial agent can be used to combat this problem. Additional local side effects that can be caused by extended use of topical steroids are epidermal atrophy, acne, glaucoma and cataracts (thus the weakest concentrations should be used in and around the eyes), pigmentation problems, hypertrichosis, allergic contact dermatitis, perioral dermatitis, and granuloma gluteale infantum (251). 

CD occurs in approximately 4.56 per 100,000 pediatric patients, and UC occurs in about 2.14 cases per 100,000.43 A major issue in children with IBD is the risk of growth failure secondary to inadequate nutritional intake. Failure to thrive may be an initial presentation of IBD in this population. Aggressive nutritional interventions may be required to facilitate adequate caloric intake. Chronic corticosteroid therapy may also be associated with reductions in growth. 

The effects of flavonoids derived from soybean, cocoa, wine, and green tea on the reduction of risk for chronic cardiovascular diseases have been studied the most. 

---